fda warning letters compounded semaglutide tirzepatide 2024 2025 Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly FDA issued 25 warning letters

Clinical trials and pooled analyses have shown that the combination has a safety profile similar to each component alone, with a low incidence of hypoglycemia (unless combined with insulin or sulfonylureas)

OpenAI and Anthropic are both partnering with private equity firms in a bid to deploy their AI products to more businesses.

*Always consult your healthcare provider before starting any supplement regimen.*

Treating obesity isn't just about weight lossit's about preserving health while losing weight

Since the body does not metabolize it, the calories are not absorbed in the digestive system, meaning it does not raise blood sugar or insulin levels